Additionally, if the mutation disrupts the protein severely enough, a transplant will expose the recipient to de novo antigens from the donor kidney, such as has been reported with NPHS1 (congenital nephrotic syndrome) and COL4A5 (Alport syndrome)39–43. Here, COL4A5 is linked to Alport syndrome.